Banamine,
finadyne,
flunixin meglumine,
Sch 14714 meglumine,
FLUNIXIN MEGLUMINE,
42461-84-7,
Flunixin meglumin,
Banamine,
finadyne,
Flumeglumine,
Flunixin-S,
Sch 14714 meglumine,
Flunixin N-methylglucanine,
Flunixin (meglumine),
Banamine (Veterinary),
UNII-8Y3JK0JW3U,
Sch-14714 meglumine,
EINECS 255-836-0,
8Y3JK0JW3U,
CHEBI:76144,
1-Deoxy-1-(methylamino)-D-glucitol 2-(2-methyl-3-(perfluoromethyl)anilino)nicotinate,
2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt,
2-(alpha(sup 3),alpha(sup 3),alpha(sup 3)-Trifluoro-2,3-xylidino)nicotinic acid compound with 1-deoxy-1-(methylamino)-D-glucitol (1:1),
1-Deoxy-1-(methylamino)-D-glucitol 2-[2-methyl-3-(perfluoromethyl)anilino]nicotinate,
2-((2-Methyl-3-(trifluoromethyl)-phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded,
3-Pyridinecarboxylic acid, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1),
D-Glucitol, 1-deoxy-1-(methylamino)-, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxylate (salt),
SMR000875279,
SR-05000001901,
Flunixin Meglumine [USAN],
Equileve,
Ilium Flunixil,
flunixin-meglumin,
Flunixin meglumine [USAN:USP],
(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid,
C14H11F3N2O2.C7H17NO5,
PubChem15394,
Flunixin meglumine (USP),
Flunixin N-Methylglucamine,
Banamine [vetarynary] (TN),
SCHEMBL43691,
BSPBio_002558,
MLS001333159,
MLS002153985,
SPECTRUM1505113,
AC1L21A7,
CHEMBL1733447,
CTK8F9789,
C21H28F3N3O7,
MGCCHNLNRBULBU-WZTVWXICSA-N,
HMS2093I10,
HMS2234K05,
Pharmakon1600-01505113,
HY-B0386,
MFCD01725419,
NIH 10250,
NSC759583,
s2108,
Flunixin meglumine, >=98% (HPLC),
AKOS015895954,
AC-6012,
API0025954,
CCG-213338,
CS-2460,
KS-5126,
NSC-759583,
KS-000010G2,
NCGC00180889-01,
2-((2-methyl-3-(trifluoromethyl)- phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded,
LS-71360,
SC-18614,
AB2000512,
FT-0626443,
SW196448-3,
D04216,
K-8817,
AB00920714_05,
AB00920714_06,
461F847,
C-22876,
I06-1248,
Q-201124,
SR-05000001901-1,
SR-05000001901-3,
Flunixin meglumine, European Pharmacopoeia (EP) Reference Standard,
Flunixin meglumine, United States Pharmacopeia (USP) Reference Standard,
2-(2-Methyl-3-trifluoromethylanilino)nicotinic Acid N-Methyl-D-glucamine Salt,
Flunixin Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material,
(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-(2-methyl-3-(trifluoromethyl)phenylamino)nicotinate,
(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; 2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid,
1-deoxy-1-(methylazaniumyl)-D-glucitol 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinate,
2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid 1-Deoxy-1-(methylamino)-D-glucitol,
2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinic acid--1-deoxy-1-(methylamino)-D-glucitol (1/1),
null,
Resflor gold,
Sch 14714,
2-chloropyrimidine-4-carbonitrile,
CID39212,
CS-T-23763,
H091,
B1445,
A11686,
Flunixin meglumine, 98.5% - 100MG 100mg,
C014558,
C14-H11-F3-N2-O2.C7-H17-N-O5,
2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate, 1-deoxy-1-(methylamino)-D-glucitol(1:1),
D-Glucitol, 1-deoxy-1-(methylamino)-, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate (salt),